.1: Causes of subfertility: Studies of populations infertility
20 %-30% revealed that A) ovulatory dysfunction 20%-35% B) tubal damage 10% -50% C) sperm dysfunction , 5%-10% D) endometriosis-10% E) 5%
cervical mucus problems
and F) 5% coital
dysfunction.. Its couples problem.
. Q.2: It is one person’s diseases!!!
A degree of subfertility is found in both partners in 30 %
- 50% of couples as usually
a couple’s subfertility is a relative rather
than an absolute barrier to conception. It should be remembered
that the greater the prevalence of a
condition the greater the predictive value of its screening test. So
everyday tests are of most value in detecting the commonest causes of subfertility.
Q.3: : Unexplained infertility’ ---Why not to wait for detailed costly
investigatios and further complex treatement ?? Is there any clear protocol when we should initiate detailed investigastins in a case of Unexplained subfertility. What is known to us about Unexplained infertility ? It has been defined as the inability to conceive
after 1 year in the absence of
any abnormalities. But fortunately, A) the natural
pregnancy rate in couples with unexplained infertility has been reported as between
2% and 4% per menstrual
cycle. One study reported B) spont conception
rates of 15% of couples with unexplained infertility within 1 year and C)
35% within 2 years . And
the D) cumulative chance of
pregnancy over 3 years has even been reported as being 80% . Therefore it has been suggested that treatment should be deferred until the couple has been
trying to conceive for 2-3 years and age of Female parter
is < 32 yrs. as before this
time therapy may not
confer any benefit over the natural
chance of
conception .
Q.4: What are
the limitations of tests designed for subfertility?? Ans: The
limitations of the various tests
however also should be appreciated .For instance A) tubal patency does not necessarily equate with normal
function and B) an elevated luteal phase progesterone concentration does not confirm that an oocyte has been released from the follicle.
Q.5 : If
one decides for tests then what tests to do?? : It is presumed that the couple had
had schedule tests like assessment
of ovulation., routine seminal analysis
, and tubal patency . Now the question that comes are supplementary investigations such as 1)
follicular scanning for entire cycle unstimulated, 2) laparoscopy
/ hysteroscopy with endometrial biopsy
and 3) complex
sperm function tests are useful in helping
to predict the chance of conception
but they may not influence th outcome
of treatment.
.
Q.6 : Etiology of Unexlained subfertility :: POSSILE
SUBTLE CAUSES PROPOSED FOR
SUBFERTILITY
Subtle causes of subfertility that have been proposed as underlying unexplained infertility many of such defects are also observed in couples of normal fertility
A) Ovarian and endocrine factors
1) Abnormal follicle
growth 2)Luteinised
unruptured follicles and 3) functional ovarian cysts 4) Hypersecretion of luteinising hormone 5)Hypersecretion of prolactin in the presence of
ovulation 6) Reduced growth
hormone secretion / sensitivity
B) Cytological abnormalities in oocytes
C) Genetic abnormalities
in oocytes
D) Antibodies to zona
pellucida
E) Peritoneal factors
F) Altered macrophage and immune
activity
G) Mild
endometriosis
H) Antichlamydial antibodies
I) Now the question arises can et afford
dfor such all tetsung in agiven cvase?.
Tubal factors
1) Abnormal peristaltic or cilial activity 2) Altered macrophage and immune activity
Endometrial
factors
1) Abnormal secretion of endometrial proteins(genetic/ inflamm)
2) abnormal integrin / adhesion
molecules 3) Abnormal T cell and natural
killer cell activity 4)Secretion
of embryotoxic factors 5)
Abnormalities
in uterine perfusion and contractility
Cervical factors
A 1) Altered
cervical mucus increased immunogenicity , 2)
General immune factors 3) Altered cell mediated immunity
Male factors
Reduction in
motility acrosome reaction oocyte
binding and zona penetration ,Ultrastructural
abnormalities of head morphology .Embyological factors . Poor quality
embryos
Reduced
progression to blastocyst in vitro
Abnormal chromosomal
complement - increased miscarriage
rate
It
appears that the most important prognostic factors are the duration of infertility and the age of the female partner . Of
course the rate of progression to treatment through
the various therapies that are
used to boost fertility will depend
upon the age of the couple and
their levels of anxiety together
with the available
resources. The management of unexplained infertility is usually
empirical but couples undergoing treatment
should always be treated as
individuals.
Management of Unexplained Infertility
Several approaches
have been used in the
management of unexplained infertility
some of the therapies that
have been used are discussed here and we
propose a stratified protocol
used in practice. Therapy should
aim to boost the monthly pregnancy
rate above the natural rate of 1.5% -3%
that is expected for couples who
have been trying to conceive
for over a year. Q.8: Doctors biasness about one spl cause for unexplained
subfertility!!! Ans: Many centres have
their own highly specialised areas of
interest and research that they then
promote as the missing cause of
unexplained infertility . Thus it
is possible to draw long lists
of putative and subtle
cause of infertility many of which cannot be proven with certainty and few of which are actually amenable to a corrective remedy that has been shown to enhance fertility
. One also should remember that couples with normal
fertility can have abnormal test
results. Once the well known and
obvious causes of infertility have been
excluded the treatment of couples
with unexplained infertility
should follow clear protocols.
Clomifene Citrate
It used to
be though that clomifene enhanced
fertility by correcting a subtle defect in ovarian
function - either of follicular development
or of luteal phase defect . It
appears more likely however that
stimulation of ovulation achieves its effect by increasing the number
of follicles that develop and consequently the oocytes that are released When
using clomifene citrate one
should always remember the side effects
of multiple pregnancy and the possible association between its prolonged use
and the putative risk of
ovarian cancer
.
Over the
years many studies have been published and systematic reviews have fluctuated in and out of favour for the use of clomifene for the management of unexplained
infertility. The latest
Cochrane review of data
relating to 1159 participants from seven randomised trials reports
no evidence that
clomifene was more effective
than no treatment or than placebo for liver
birth or for clinical pregnancy both with intrauterine insemination without
and without IUI but
using human chorionic
gonadotropin.
Superovulation with IUI
There are
few prospective randomised studies involving the use of gonadotropins
alone in the treatment of
unexplained infertility and most of the studies that have
evaluated gonadotropins with IUI are
retrospective analyses. Gonadotropin therapy requires
careful monitoring with
serial ultrasound scans
to minimise the risks of ovarian
hyperstimulation syndrome and multiple
pregnancy .
It is reasonable
to expect that the
combination of gonadotropins to induce
super ovulation with the
release of two or three oocytes with
insemination of a prepared sample sperm
into the uterine cavity should boost fertility. There are however contrasting studies in the literature. Melis et al have
reported a large prospective randomized study comparing gonadotropin therapy
and timed intercourse with gonadotropin therapy and IUI . Two
hundred couples with at least 3 years
unexplained infertility received
superovulation with follicle stimulating hormone to
produce at least two follicles. There was no significant difference
in the outcome of the two groups with a cumulative conception rate of
approximately 43% after
three cycles and a multiple pregnancy
rate of 10 % . A similar study from
Glasgow randomised 100 patients
to receive ovulation induction using pituitary
desensitization with a gonadotropin releasing hormone agonist followed by
FSH with timed intercourse of IUI group compared with
18% in the timed intercourse
group.
No comments:
Post a Comment